Acadian Asset Management’s ENZON PHARMACEUTICALS INC ENZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q3 | – | Sell |
-122,287
| Closed | -$50K | – | 1670 |
|
|
2016
Q2 | $50K | Buy |
122,287
+8,847
| +8% | +$3.62K | ﹤0.01% | 1097 |
|
|
2016
Q1 | $54K | Buy |
113,440
+4,368
| +4% | +$2.08K | ﹤0.01% | 1084 |
|
|
2015
Q4 | $75K | Sell |
109,072
-8,910
| -8% | -$6.13K | ﹤0.01% | 1101 |
|
|
2015
Q3 | $115K | Sell |
117,982
-17,046
| -13% | -$16.6K | ﹤0.01% | 973 |
|
|
2015
Q2 | $161K | Hold |
135,028
| – | – | ﹤0.01% | 962 |
|
|
2015
Q1 | $145K | Buy |
135,028
+12,901
| +11% | +$13.9K | ﹤0.01% | 972 |
|
|
2014
Q4 | $133K | Hold |
122,127
| – | – | ﹤0.01% | 955 |
|
|
2014
Q3 | $132K | Sell |
122,127
-7,925
| -6% | -$8.57K | ﹤0.01% | 807 |
|
|
2014
Q2 | $135K | Hold |
130,052
| – | – | ﹤0.01% | 839 |
|
|
2014
Q1 | $134K | Hold |
130,052
| – | – | ﹤0.01% | 820 |
|
|
2013
Q4 | $151K | Sell |
130,052
-35,942
| -22% | -$41.7K | ﹤0.01% | 834 |
|
|
2013
Q3 | $279K | Buy |
165,994
+17,046
| +11% | +$28.7K | ﹤0.01% | 716 |
|
|
2013
Q2 | $298K | Buy |
+148,948
| New | +$298K | ﹤0.01% | 657 |
|